Clinical Trials Logo

Filter by:
NCT ID: NCT01847781 Completed - IgG Deficiency Clinical Trials

PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency

PNEUMOCELL
Start date: May 2013
Phase: Phase 2
Study type: Interventional

The aim is to study the immune response to conjugated pneumococcal vaccination (Prevenar13) in Immunoglobulin G-deficient patients and healthy controls. Our hypothesis is that the antibody response will be impaired in patients as compared with controls. In contrast, we postulate that the cellular immune response will be intact.

NCT ID: NCT01847703 Completed - Clinical trials for Endometrial Neoplasms

Robotic Versus Abdominal Surgery for Endometrial Cancer

RASHEC
Start date: April 2013
Phase: N/A
Study type: Interventional

This study is intended to explore differences in oncologic and surgical safety between robotic assisted laparoscopy and conventional abdominal surgery for high risk endometrial cancer.

NCT ID: NCT01847274 Completed - Ovarian Neoplasms Clinical Trials

A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Start date: June 21, 2013
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study of niraparib as maintenance in platinum sensitive ovarian cancer patients who have either gBRCAmut or a tumor with high-grade serous histology and who have responded to their most recent chemotherapy containing a platinum agent. Niraparib is an orally active PARP inhibitor. Niraparib or placebo (in a 2:1 ratio) will be administered once daily continuously during a 28-day cycle. Health-related quality of life will be measured by the Functional Assessment of Cancer Therapy - Ovarian Symptom Index (FOSI), European Quality of Life scale, 5-Dimensions (EQ-5D), and a neuropathy questionnaire. Safety and tolerability will be assessed by clinical review of adverse events (AEs), physical examinations, electrocardiograms (ECGs), and safety laboratory values. The primary objective of this study is to evaluate efficacy of niraparib as maintenance therapy in patients who have platinum sensitive ovarian cancer as assessed by the prolongation of progression free survival (PFS).

NCT ID: NCT01844947 Completed - Bladder Cancer Clinical Trials

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

VINSOR
Start date: May 2012
Phase: Phase 1
Study type: Interventional

This study aims to analyse the tolerability (side effects and safety) with standard treatment (Javlor®) with the addition of a second anti-tumour drug: sorafenib (Nexavar®). This is the first time this treatment combination is studied in humans. Samples of blood, urine and tumour tissues will be analysed for molecular biomarkers. These biomarkers may potentially help us in the future in predicting whether a patient will benefit or not from the cancer treatment. The study also aims to investigate if a newer imaging method, called PET-CT (positron emission tomography-computed tomography), at an earlier stage (than a normal CT scan) can identify patients who will benefit from the given treatment.

NCT ID: NCT01844362 Completed - Clinical trials for Primary Uterine Infertility

Uterus Transplantation From Live Donor

utx
Start date: September 2012
Phase: N/A
Study type: Interventional

Uterus transplantation, as a possible future treatment for uterine factor infertility, has been developed in animal species during the last decade. The study protocol includes transplantation of the uterus from a live donor (mother, relative, friend) into women with absolute uterine factor infertility (lack of uterus from birth or due to life saving hysterectomy).The recipient will be treated by standard immunosuppression and transfer of embryos (acquired by IVF before surgery) will be attempted when at least 12 months have passed from transplantation. Approval for a case series including up to 10 patients has been acquired.

NCT ID: NCT01844336 Completed - Idiopathic Rhinitis Clinical Trials

PBASE System Idiopathic Rhinitis Clinical Investigation

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the performance of the PBASE system, in terms of the efficacy of treatment in patients with idiopathic rhinitis.

NCT ID: NCT01842945 Completed - Procrastination Clinical Trials

Internet Based Cognitive Behavior Therapy for Procrastination: A Randomized Controlled Trial

Start date: August 2013
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effects of cognitive behavior therapy (CBT) for procrastination, and to investigate whether it can be delivered via the Internet. Two treatment groups will be used, one with therapist contact and one without, as well as a wait-list control group. It is assumed that the treatment group with therapist contact will be superior to the treatment group receiving no therapist contact since procrastination can be partially explained as a self-regulatory failure. Both treatment groups are presumed to be superior to the wait-list control.

NCT ID: NCT01841853 Completed - Health Behavior Clinical Trials

RCT of Health-promoting Intervention for Older Foreign-born Adults

Start date: August 2012
Phase: N/A
Study type: Interventional

The overarching aim with this study was to develop, implement and evaluate a health promoting programme for people from Finland or the Western Balkan region, who were 70 years of age or older and independent daily activites (1). The aim of the programme was to prevent or delay dependence in daily activities, health decline, and frailty. The study focused on both evaluation and implementation and the data collection finished in 2016

NCT ID: NCT01841151 Completed - Clinical trials for Attention Deficit Disorder

Neurofeedback and Working Memory Training for Children and Adolescents With ADHD

KITE
Start date: August 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate if neurofeedback and working memory training improves core symptoms of ADHD in children and adolescents.

NCT ID: NCT01838681 Completed - Clinical trials for Major Depressive Disorder

Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Start date: June 2013
Phase: Phase 3
Study type: Interventional

To evaluate the maintenance of efficacy and safety during long-term treatment with brexpiprazole as an adjunctive treatment for adult subjects with Major Depressive Disorder (MDD)